Comparison of core needle biopsy and fine-needle aspiration methods in CT-guided percutaneous sampling of pancreatic tumors

To compare the diagnostic efficacy and safety of CT-guided percutaneous core needle biopsy (CNB) and fine-needle aspiration (FNA) for pancreatic lesions. A total of 176 patients with 176 pancreatic lesions who visited our hospital between January 2016 and March 2021 were retrospectively analyzed. Th...

Full description

Saved in:
Bibliographic Details
Published inJournal of cancer research and therapeutics Vol. 19; no. 4; pp. 904 - 909
Main Authors Liu, Jingjing, Huang, Wei, Wang, Shenjie, Wu, Zhiyuan, Wang, Ziyin, Ding, Xiaoyi, Wang, Zhongmin
Format Journal Article
LanguageEnglish
Published Mumbai Medknow Publications and Media Pvt. Ltd 01.08.2023
Medknow Publications & Media Pvt. Ltd
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To compare the diagnostic efficacy and safety of CT-guided percutaneous core needle biopsy (CNB) and fine-needle aspiration (FNA) for pancreatic lesions. A total of 176 patients with 176 pancreatic lesions who visited our hospital between January 2016 and March 2021 were retrospectively analyzed. They were divided into three groups: FNA group A (<1.5 cm between the lesion and great vessels necessitating FNA), FNA group B, and CNB (the latter two with ≥1.5 cm between the lesion and great vessels necessitating FNA). The sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and postoperative. The statistical analysis was done using Statistical Package for the Social Sciences version 17.0. One hundred and seventy six patient's specimens all met the requirements. There were no statistically significant differences in sensitivity, specificity, positive predictive value, negative predictive value, and accuracy between the CNB group and FNA group B, (P > 0.05). Thirteen samples submitted for genetic testing (5 in CNB group, 4 in each of the FNA groups A and B) all met the standards of next-generation sequencing gene detection. The main complications of these groups included abdominal pain, fever, and hyperamylasemia. CT-guided percutaneous FNA and CNB have similar diagnostic efficacy for pancreatic biopsy. Furthermore, FNA has a wide range of puncture indications and is very safe. Like CNB, the obtained tissue through FNA can be genetically tested to guide clinical treatment.
AbstractList ABSTRACTAims:To compare the diagnostic efficacy and safety of CT-guided percutaneous core needle biopsy (CNB) and fine-needle aspiration (FNA) for pancreatic lesions.Methods and Material:A total of 176 patients with 176 pancreatic lesions who visited our hospital between January 2016 and March 2021 were retrospectively analyzed. They were divided into three groups: FNA group A (<1.5 cm between the lesion and great vessels necessitating FNA), FNA group B, and CNB (the latter two with ≥1.5 cm between the lesion and great vessels necessitating FNA). The sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and postoperative. The statistical analysis was done using Statistical Package for the Social Sciences version 17.0.Results:One hundred and seventy six patient’s specimens all met the requirements. There were no statistically significant differences in sensitivity, specificity, positive predictive value, negative predictive value, and accuracy between the CNB group and FNA group B, (P > 0.05). Thirteen samples submitted for genetic testing (5 in CNB group, 4 in each of the FNA groups A and B) all met the standards of next-generation sequencing gene detection. The main complications of these groups included abdominal pain, fever, and hyperamylasemia.Conclusions:CT-guided percutaneous FNA and CNB have similar diagnostic efficacy for pancreatic biopsy. Furthermore, FNA has a wide range of puncture indications and is very safe. Like CNB, the obtained tissue through FNA can be genetically tested to guide clinical treatment.
To compare the diagnostic efficacy and safety of CT-guided percutaneous core needle biopsy (CNB) and fine-needle aspiration (FNA) for pancreatic lesions. A total of 176 patients with 176 pancreatic lesions who visited our hospital between January 2016 and March 2021 were retrospectively analyzed. They were divided into three groups: FNA group A (<1.5 cm between the lesion and great vessels necessitating FNA), FNA group B, and CNB (the latter two with ≥1.5 cm between the lesion and great vessels necessitating FNA). The sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and postoperative. The statistical analysis was done using Statistical Package for the Social Sciences version 17.0. One hundred and seventy six patient's specimens all met the requirements. There were no statistically significant differences in sensitivity, specificity, positive predictive value, negative predictive value, and accuracy between the CNB group and FNA group B, (P > 0.05). Thirteen samples submitted for genetic testing (5 in CNB group, 4 in each of the FNA groups A and B) all met the standards of next-generation sequencing gene detection. The main complications of these groups included abdominal pain, fever, and hyperamylasemia. CT-guided percutaneous FNA and CNB have similar diagnostic efficacy for pancreatic biopsy. Furthermore, FNA has a wide range of puncture indications and is very safe. Like CNB, the obtained tissue through FNA can be genetically tested to guide clinical treatment.
ABSTRACT Aims: To compare the diagnostic efficacy and safety of CT-guided percutaneous core needle biopsy (CNB) and fine-needle aspiration (FNA) for pancreatic lesions. Methods and Material: A total of 176 patients with 176 pancreatic lesions who visited our hospital between January 2016 and March 2021 were retrospectively analyzed. They were divided into three groups: FNA group A (<1.5 cm between the lesion and great vessels necessitating FNA), FNA group B, and CNB (the latter two with ≥1.5 cm between the lesion and great vessels necessitating FNA). The sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and postoperative. The statistical analysis was done using Statistical Package for the Social Sciences version 17.0. Results: One hundred and seventy six patient's specimens all met the requirements. There were no statistically significant differences in sensitivity, specificity, positive predictive value, negative predictive value, and accuracy between the CNB group and FNA group B, (P > 0.05). Thirteen samples submitted for genetic testing (5 in CNB group, 4 in each of the FNA groups A and B) all met the standards of next-generation sequencing gene detection. The main complications of these groups included abdominal pain, fever, and hyperamylasemia. Conclusions: CT-guided percutaneous FNA and CNB have similar diagnostic efficacy for pancreatic biopsy. Furthermore, FNA has a wide range of puncture indications and is very safe. Like CNB, the obtained tissue through FNA can be genetically tested to guide clinical treatment. Keywords: Aspiration biopsy, CT-guided fine needle, genetic testing, pancreatic neoplasms
AimsTo compare the diagnostic efficacy and safety of CT-guided percutaneous core needle biopsy (CNB) and fine-needle aspiration (FNA) for pancreatic lesions. Methods and MaterialA total of 176 patients with 176 pancreatic lesions who visited our hospital between January 2016 and March 2021 were retrospectively analyzed. They were divided into three groups: FNA group A (<1.5 cm between the lesion and great vessels necessitating FNA), FNA group B, and CNB (the latter two with ≥1.5 cm between the lesion and great vessels necessitating FNA). The sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and postoperative. The statistical analysis was done using Statistical Package for the Social Sciences version 17.0. ResultsOne hundred and seventy six patient's specimens all met the requirements. There were no statistically significant differences in sensitivity, specificity, positive predictive value, negative predictive value, and accuracy between the CNB group and FNA group B, (P > 0.05). Thirteen samples submitted for genetic testing (5 in CNB group, 4 in each of the FNA groups A and B) all met the standards of next-generation sequencing gene detection. The main complications of these groups included abdominal pain, fever, and hyperamylasemia. ConclusionsCT-guided percutaneous FNA and CNB have similar diagnostic efficacy for pancreatic biopsy. Furthermore, FNA has a wide range of puncture indications and is very safe. Like CNB, the obtained tissue through FNA can be genetically tested to guide clinical treatment.
Audience Professional
Author Liu, Jingjing
Wang, Shenjie
Huang, Wei
Wang, Ziyin
Wu, Zhiyuan
Wang, Zhongmin
Ding, Xiaoyi
Author_xml – sequence: 1
  fullname: Liu, Jingjing
– sequence: 2
  fullname: Huang, Wei
– sequence: 3
  fullname: Wang, Shenjie
– sequence: 4
  fullname: Wu, Zhiyuan
– sequence: 5
  fullname: Wang, Ziyin
– sequence: 6
  fullname: Ding, Xiaoyi
– sequence: 7
  fullname: Wang, Zhongmin
BookMark eNptkkFrGzEQhUVJoE7aH9CboJde1tFIWks6BtOmhUAu6VnI0qwrsyttpN1D6J_vOg40LWZgBobvPQbmXZGLlBMS8gnYWgITNwdfpvWxWeCGWc7fkRUYoxsJQl-QFTNKNCA1f0-uaj0w1irO9Yr83uZhdCXWnGjuqM8FaUIMPdJdzGN9pi4F2sWEzeva1TEWN8VFMOD0K4dKY6Lbx2Y_x4CBjlj8PLmEea60umHsY9ofvUeXfMFF6ek0D7nUD-Syc33Fj6_zmvz89vVx-725f7j7sb29b7xs5dRsguIQvA7tZueZDsA1MwZB7VrHpN9hcFL4VhgFLVdSdppBkCi90p3hXolr8uXkO5b8NGOd7BCrx74_HWm53nAwmut2QT__hx7yXNJynRUAIIXSrfpL7V2PNqYuT8X5o6m91aA5E8bAQjVnqD0mLK5fvtfFZf0Pvz7DLxVwiP6sAE4CX3KtBTs7lji48myB2WMq7Esg3qZC_AEY2a6D
CitedBy_id crossref_primary_10_4103_jcrt_jcrt_1761_23
Cites_doi 10.1097/00004728-200209000-00014
10.4103/jcrt.JCRT_1663_20
10.1002/jcu.22362
10.3748/wjg.v21.i12.3579
10.4103/jcrt.JCRT_803_20
10.1007/s00280-015-2788-6
10.1016/S1470-2045(19)30691-6
10.1016/j.clinimag.2014.06.010
10.1093/annonc/mdx343
10.4103/jcrt.JCRT_755_18
10.3322/caac.21551
10.1016/j.jvir.2010.01.011
10.4103/jcrt.JCRT_408_18
10.6004/jnccn.2019.0014
10.6004/jnccn.2021.0017
10.2214/AJR.05.0366
10.1016/j.carj.2018.10.014
10.1007/s00330-015-4003-x
10.3748/wjg.v19.i15.2368
10.1200/JCO.19.02105
10.1056/NEJMoa1903387
10.1016/S0140-6736(20)30974-0
10.4103/jcrt.JCRT_563_20
ContentType Journal Article
Copyright COPYRIGHT 2023 Medknow Publications and Media Pvt. Ltd.
2023. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: COPYRIGHT 2023 Medknow Publications and Media Pvt. Ltd.
– notice: 2023. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
K9.
7X8
DOI 10.4103/jcrt.jcrt_1290_22
DatabaseName CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)



MEDLINE - Academic
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1998-4138
EndPage 909
ExternalDocumentID A818203991
10_4103_jcrt_jcrt_1290_22
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
29K
2WC
3V.
53G
5GY
5VS
7X7
88E
8FI
8FJ
8G5
AAWTL
AAYXX
ABDBF
ABJNI
ABUWG
ABXLX
ACGFS
ADBBV
AENEX
AFKRA
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
D-I
DIK
DU5
DWQXO
E3Z
EBD
EBS
EJD
EMOBN
EOJEC
ESX
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
H13
HMCUK
IAO
IEA
IHE
IHR
IL9
INH
INR
IOF
IPNFZ
IPO
ITC
KQ8
M1P
M2O
M~E
OBODZ
OK1
OVD
P2P
P6G
PIMPY
PQQKQ
PROAC
PSQYO
RBI
RIG
RMW
RNS
SV3
TEORI
TR2
TUS
UKHRP
W3E
XSB
~8M
K9.
7X8
ID FETCH-LOGICAL-c454t-6d721dc8d56bc08d128099e17b5a04cbeda43c5397152744f801d4e4c78f92c73
ISSN 0973-1482
IngestDate Wed Dec 04 02:50:54 EST 2024
Thu Dec 05 14:35:11 EST 2024
Thu Dec 05 14:59:49 EST 2024
Thu Dec 05 17:33:28 EST 2024
Thu Dec 05 09:30:37 EST 2024
Fri Dec 06 07:07:47 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c454t-6d721dc8d56bc08d128099e17b5a04cbeda43c5397152744f801d4e4c78f92c73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doi.org/10.4103/jcrt.jcrt_1290_22
PQID 3111437857
PQPubID 226490
PageCount 6
ParticipantIDs proquest_miscellaneous_2862198285
proquest_journals_3111437857
gale_infotracmisc_A818203991
gale_infotracgeneralonefile_A818203991
gale_infotracacademiconefile_A818203991
crossref_primary_10_4103_jcrt_jcrt_1290_22
PublicationCentury 2000
PublicationDate 2023-08-00
20230801
PublicationDateYYYYMMDD 2023-08-01
PublicationDate_xml – month: 08
  year: 2023
  text: 20230801
  day: 01
PublicationDecade 2020
PublicationPlace Mumbai
PublicationPlace_xml – name: Mumbai
PublicationTitle Journal of cancer research and therapeutics
PublicationYear 2023
Publisher Medknow Publications and Media Pvt. Ltd
Medknow Publications & Media Pvt. Ltd
Publisher_xml – sequence: 0
  name: Medknow Publications and Media Pvt. Ltd
– sequence: 0
  name: Medknow Publications & Media Pvt. Ltd
References Matsuyama (R9-20241021) 2013; 19
Gai (R4-20241021) 2021; 17
Yang (R11-20241021) 2015; 39
Tyng (R16-20241021) 2015; 21
Karabulut (R25-20241021) 2020; 16
Tempero (R7-20241021) 2021; 19
Gupta (R14-20241021) 2010; 21
Zech (R12-20241021) 2002; 26
Stella (R8-20241021) 2019; 70
Marabelle (R23-20241021) 2020; 38
Kahriman (R13-20241021) 2016; 44
Zhu (R6-20241021) 2019; 15
Mizrahi (R1-20241021) 2020; 395
Yang (R2-20241021) 2021; 17
Sohal (R18-20241021) 2020; 5
Putnik (R17-20241021) 2001; 58
Siegel (R5-20241021) 2019; 69
Golan (R21-20241021) 2019; 381
Doebele (R24-20241021) 2020; 21
Tempero (R26-20241021) 2019; 17
Paulsen (R15-20241021) 2006; 187
Fogelman (R22-20241021) 2015; 76
D'Onofrio (R10-20241021) 2016; 26
Wei (R3-20241021) 2021; 17
Schultheis (R20-20241021) 2017; 28
(R19-20241021) 2021
References_xml – volume: 26
  start-page: 743
  year: 2002
  ident: R12-20241021
  article-title: Large core biopsy of thepancreas under CT fluoroscopy control:Results and complications
  publication-title: J Comput Assist Tomogr
  doi: 10.1097/00004728-200209000-00014
  contributor:
    fullname: Zech
– volume: 17
  start-page: 613
  year: 2021
  ident: R3-20241021
  article-title: Chinese expert consensus of image-guided irreversible electroporation for pancreatic cancer
  publication-title: J Cancer Res Ther
  doi: 10.4103/jcrt.JCRT_1663_20
  contributor:
    fullname: Wei
– volume: 58
  start-page: 357
  year: 2001
  ident: R17-20241021
  article-title: Complications in percutaneous aspiration biopsy of thepancreas
  publication-title: Vojnosanit Pregl
  contributor:
    fullname: Putnik
– volume: 44
  start-page: 470
  year: 2016
  ident: R13-20241021
  article-title: Percutaileous ultrasound-guided core needle biopsy of solid pancreatic massses:Results in 250 patients
  publication-title: J Clin Ultrasound
  doi: 10.1002/jcu.22362
  contributor:
    fullname: Kahriman
– volume: 21
  start-page: 3579
  year: 2015
  ident: R16-20241021
  article-title: Computed tomography-guided percutaneous core needle biopsy in pancreatic tumor diagnosis
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v21.i12.3579
  contributor:
    fullname: Tyng
– volume: 17
  start-page: 702
  year: 2021
  ident: R4-20241021
  article-title: Advantages of interstitial radioactive seed implantation for the treatment of Stage III pancreatic cancer
  publication-title: J Cancer Res Ther
  doi: 10.4103/jcrt.JCRT_803_20
  contributor:
    fullname: Gai
– volume: 76
  start-page: 489
  year: 2015
  ident: R22-20241021
  article-title: Family history as a marker of platinum sensitivity in pancreatic adenocarcinoma
  publication-title: Cancer Chemother Pharmacol
  doi: 10.1007/s00280-015-2788-6
  contributor:
    fullname: Fogelman
– volume: 21
  start-page: 271
  year: 2020
  ident: R24-20241021
  article-title: Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours:Integrated analysis of three phase 1-2 trials
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(19)30691-6
  contributor:
    fullname: Doebele
– volume: 39
  start-page: 62
  year: 2015
  ident: R11-20241021
  article-title: Evaluation of percutaneous ultrasound-guided biopsies of solid mass lesions of the pancreas:A center's 10-year experience
  publication-title: Clin Imaging
  doi: 10.1016/j.clinimag.2014.06.010
  contributor:
    fullname: Yang
– volume: 28
  start-page: 2429
  year: 2017
  ident: R20-20241021
  article-title: Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer:A multicenter, randomized phase IIb study
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdx343
  contributor:
    fullname: Schultheis
– volume: 16
  start-page: 110
  year: 2020
  ident: R25-20241021
  article-title: Circulating annexin A2 as a biomarker in patients with pancreatic cancer
  publication-title: J Cancer Res Ther
  doi: 10.4103/jcrt.JCRT_755_18
  contributor:
    fullname: Karabulut
– volume: 69
  start-page: 7
  year: 2019
  ident: R5-20241021
  article-title: Cancer statistics, 2019
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21551
  contributor:
    fullname: Siegel
– volume: 21
  start-page: 969
  year: 2010
  ident: R14-20241021
  article-title: Quality improvement guidelines for percutaneous needle biopsy
  publication-title: J Vasc Interv Radiol
  doi: 10.1016/j.jvir.2010.01.011
  contributor:
    fullname: Gupta
– volume: 15
  start-page: 831
  year: 2019
  ident: R6-20241021
  article-title: High-intensity focused ultrasound ablation for advanced pancreatic cancer
  publication-title: J Cancer Res Ther
  doi: 10.4103/jcrt.JCRT_408_18
  contributor:
    fullname: Zhu
– volume: 5
  year: 2020
  ident: R18-20241021
  article-title: Metastatic pancreatic cancer:ASCO guideline update
  publication-title: J Clin Oncol
  contributor:
    fullname: Sohal
– volume: 17
  start-page: 202
  year: 2019
  ident: R26-20241021
  article-title: Pancreatic Adenocarcinoma. version 1.2019
  publication-title: J Narl Compr Canc Netw
  doi: 10.6004/jnccn.2019.0014
  contributor:
    fullname: Tempero
– volume: 19
  start-page: 439
  year: 2021
  ident: R7-20241021
  article-title: Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology
  publication-title: J Natl Compr Cancer Netw
  doi: 10.6004/jnccn.2021.0017
  contributor:
    fullname: Tempero
– volume: 187
  start-page: 769
  year: 2006
  ident: R15-20241021
  article-title: Evaluation of imaging-guided core biopsy of pancreatic mass
  publication-title: AJR Am Roentgenol
  doi: 10.2214/AJR.05.0366
  contributor:
    fullname: Paulsen
– volume: 70
  start-page: 199
  year: 2019
  ident: R8-20241021
  article-title: Image-guided percutaneous biopsy for pancreatic lesions:10-year experience in a tertiary cancer center
  publication-title: Can Assoc Radiol J
  doi: 10.1016/j.carj.2018.10.014
  contributor:
    fullname: Stella
– year: 2021
  ident: R19-20241021
  publication-title: Pancreatic adenocarcinoma
– volume: 26
  start-page: 1801
  year: 2016
  ident: R10-20241021
  article-title: Ultrasound-guided percutaneous fine-needle aspiration of solid pancreatic neoplasms:10-year experience with more than 2,000 cases and a review of the literature
  publication-title: Eur Radiol
  doi: 10.1007/s00330-015-4003-x
  contributor:
    fullname: D'Onofrio
– volume: 19
  start-page: 2368
  year: 2013
  ident: R9-20241021
  article-title: Ultrasound-guided vs endoscopic ultrasound-guided fine-needle aspiration for pancreatic cancer diagnosis
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v19.i15.2368
  contributor:
    fullname: Matsuyama
– volume: 38
  start-page: 1
  year: 2020
  ident: R23-20241021
  article-title: Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability/mismatch repair-deficient cancer:Results from the phase 2 KEYNOTE-158 study
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.19.02105
  contributor:
    fullname: Marabelle
– volume: 381
  start-page: 317
  year: 2019
  ident: R21-20241021
  article-title: Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1903387
  contributor:
    fullname: Golan
– volume: 395
  start-page: 2008
  year: 2020
  ident: R1-20241021
  article-title: Pancreatic cancer
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30974-0
  contributor:
    fullname: Mizrahi
– volume: 17
  start-page: 720
  year: 2021
  ident: R2-20241021
  article-title: The clinical efficacy of computed tomography-guided 125I particle implantation combined with arterial infusion chemotherapy in the treatment of pancreatic cancer
  publication-title: J Cancer Res Ther
  doi: 10.4103/jcrt.JCRT_563_20
  contributor:
    fullname: Yang
SSID ssj0057228
Score 2.3622618
Snippet ABSTRACT Aims: To compare the diagnostic efficacy and safety of CT-guided percutaneous core needle biopsy (CNB) and fine-needle aspiration (FNA) for pancreatic...
To compare the diagnostic efficacy and safety of CT-guided percutaneous core needle biopsy (CNB) and fine-needle aspiration (FNA) for pancreatic lesions. A...
ABSTRACTAims:To compare the diagnostic efficacy and safety of CT-guided percutaneous core needle biopsy (CNB) and fine-needle aspiration (FNA) for pancreatic...
AimsTo compare the diagnostic efficacy and safety of CT-guided percutaneous core needle biopsy (CNB) and fine-needle aspiration (FNA) for pancreatic lesions....
SourceID proquest
gale
crossref
SourceType Aggregation Database
StartPage 904
SubjectTerms Biopsy
Biopsy, Needle
Care and treatment
Comparative analysis
CT imaging
Methods
Pancreatic tumors
Title Comparison of core needle biopsy and fine-needle aspiration methods in CT-guided percutaneous sampling of pancreatic tumors
URI https://www.proquest.com/docview/3111437857
https://search.proquest.com/docview/2862198285
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXKJiFeEAwQhVEZCQ2JLFuTOF-PoxpMiE0V6kTFS5Q4zpoK2qpNkAp_hp_Kvbbz0a4Pg5eoSlIn8j2xj-1zjwl5E7OA2VZmwYckXJOFMTNDL4jNILFEP3F8YByYKHx55V1cs09jd9zp_GmplsoiOeG_duaV_E9U4RzEFbNk_yGydaFwAn5DfOEIEYbjnWI8aG8iaKAhpTGD3ui7MJJ8vlgpa6UMeKSpT8dqXR1DrraOlmrYwci8KfMUqOdCLHkJdFGgMHYVo9pci6IBHJJecqMof8z1EtBtUssRREtDWwhNKn1mleJVE_jPeSnxA8VPq85TgktPX38VeTPVr2e0J2I2zZulJFnAt0m-LjXA9dyF7dTKOa1f2sr4k9I_qS_BrBlj-LM4aYmb5KSl75joXLrRfoctnLJWYxyqjY23Owlm9dGsYsqXUE9wiHAqLlLZ0Vve22cB-tsDh4Px9T5aLeLuDB_HtYjI9W25e2_9XmrdHJ9weqv8Deazu_-XpGb0iDzUgaNnClqPSUfMDsj9S623OCBHQ-Vsvj6mo1YUj-kRHTae5-sn5HcDRTrPKEKRKsxRBUUKFU5bUKQNFKmGIs1ntIYibUORVlDEshsoUgXFp-T6w_locGHqfT1MzlxWmF7q21bKg9T1Et4PUqBIME4Rlp-4cZ_xRKQxc7gLTBn3XGYsAxaVMsG4H2ShzX3nGdmbzWfiOaFWFroiCGLXFSnjoRML20187gnoZuzUs7rkXVXn0ULZt0Qw7MUARTI27QB1yVuMSoRgKZYxj3WGCjwKTdKiBg1dcrRx542yiN914-HGjdB2883LFQAi3a6sIgfoB3P8wPW75HV9Gf-JekhZ7ZEdeEA10H3yxV1f5SV50HyCh2SvWJbiFRDqIumRe_7Y75H99-dXwy89ifC_6ZXX8g
link.rule.ids 314,780,784,27924,27925,31719,31720,33744,33745
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+core+needle+biopsy+and+fine-needle+aspiration+methods+in+CT-guided+percutaneous+sampling+of+pancreatic+tumors&rft.jtitle=Journal+of+cancer+research+and+therapeutics&rft.au=Liu%2C+Jingjing&rft.au=Huang%2C+Wei&rft.au=Wang%2C+Shenjie&rft.au=Wu%2C+Zhiyuan&rft.date=2023-08-01&rft.pub=Medknow+Publications+and+Media+Pvt.+Ltd&rft.issn=0973-1482&rft.volume=19&rft.issue=4&rft.spage=904&rft_id=info:doi/10.4103%2Fjcrt.jcrt_1290_22&rft.externalDocID=A818203991
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0973-1482&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0973-1482&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0973-1482&client=summon